Search Back New search Go to resultsDiseaseMain groupHematologic NeoplasmsProtocol groupAggressive LymphomasHodgkin LymphomaIndolent LymphomasT-Cell and NK-Cell NeoplasmsDiseaseHodgkin LymphomaMantle Cell LymphomaNHL, B-Cell Type, Anaplastic Large Cell Lymphoma, ALK-PositiveNHL, B-Cell Type, Diffuse Large CellNHL, B-Cell Type, Follicular Grade I-IIIaNHL, B-Cell Type, Follicular grade IIIbNHL, B-Cell Type, Mediastinal (Thymic) Large B-Cell LymphomaNHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK-positiveNHL, T-Cell Type, Anaplastic Large Cell Lymphoma, ALK negativeNHL, T-Cell Type, AngioimmunoblasticNHL, T-Cell Type, Enteropathy TypeNHL, T-Cell Type, HepatosplenicNHL, T-Cell Type, Other Specified Leukemias, Aggressive NK-Cell LeukemiaNHL, T-Cell Type, Peripheral, UnspecifiedSubgroupICD10C81.-C82.-C82.7C82.9C83.1C83.3C84.4C84.6C84.7C85.2C86.1C86.2C86.5C94.7-MeSHLymphoma, Large-Cell, AnaplasticLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, T-Cell, PeripheralSequenceSTUDY - levelChemotherapyChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneEtoposideGemcitabineMethylprednisoloneNivolumabOxaliplatinChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneEtoposideGemcitabineMethylprednisoloneNivolumabOxaliplatinChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneEtoposideGemcitabineMethylprednisoloneNivolumabOxaliplatinChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneEtoposideGemcitabineMethylprednisoloneNivolumabOxaliplatinNo. Substances1234 RadiotherapySupportive therapySupportive substanceAciclovirBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceAciclovirBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceAciclovirBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideSupportive substanceAciclovirBalanced Crystalloid SolutionCiprofloxacinCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronMagnesiumMagnesium sulfatePegfilgrastimPotassium chlorideNo. Substances14578Protocol classificationTherapy classificationalternativeStudy protocol, currentIntensityStandard doseTherapy indicationFirst lineRelapse therapySecond lineseveral possibleTherapy phaseConsolidationInductionTherapy intentioncurativepalliativeRisksAlopeciaAnemia Hb below 8g/dlCardiotoxicityConstipationDiarrheaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaGastrointestinal ToxicityHyperglycemiaHypertensionInfectionsMucositisNeuropathyNeutropeniaRenal FailureSepsisThrombocytopenia below 50 000/µlThromboembolic Event only studiesPublicationAuthorGleeson MHeld GPhillips AATessoulin BVelasquez WSDiseaseAdultes T-Zell Lymphom, rezidiviert oder therapierefraktär, ECOG 0-2Lymphom, Rezidiv oder refraktär, mit mindestens einer anthrazyklinhaltigen VortherapieNon-Hodgkin-Lymphom / Hodgkin Lymphomrezidivierendes (erstlinie mit Anthrazyklin) oder fortschreitendes aggressives NHL, > 65 Jahre oder >18 mit HCT-Cl score > 2, ECOG 0-2rezidivierendes oder fortschreitendes aggressives NHL, > 65 Jahre oder >18 mit HCT-Cl score > 2T-Zell-Lymphom, Stadium I-IV, ECOG 0-3OriginInternal Medicine I Saarland University Medical School, DSHNHL 2015-1Nantes Medical University, Nantes, FranceSection of Lymphoma, M.D. Anderson Cancer Center, Houston, TXThe Royal Marsden NHS Foundation Trust, London and Surrey, UKWeill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA Protocols in Revision 8 protocols foundProtocols under revision.DHAC - Carboplatin 5 / Cytarabine 2000 / Dexamethasone 40, Non-Hodgkin Lymphoma / Hodgkin Lymphoma. (PID2346 V1.0)ESHAP - Etoposide 40 / Cisplatin 25 / Cytarabine 2000 / Methylprednisolone 375, Non-Hodgkin Lymphoma. (PID2348 V1.0)Gemcitabine 1000 / Cisplatin 100 / Methylprednisolone 1000, T-cell Lymphoma (PID2354 V1.0)GemOx - Gemcitabine 1000 / Oxaliplatin 100, T-cell Lymphoma (PID2350 V1.0)Study - Level - Gemcitabine 1000 / Oxaliplatin 100, Aggressive Non-Hodgkin Lymphoma (PID972 V1.0)Study - Level - Nivolumab 240 / Gemcitabine 1000 / Oxaliplatin 100, diffuse large B-Non-Hodgkin Lymphoma, Cycle 1 (PID968 V1.2)Study - level - Nivolumab 240 / Gemcitabine 1000 / Oxaliplatin 100, diffuse large B-Non-Hodgkin Lymphoma, cycle 2+ (PID970 V1.2)Study - Level - Nivolumab 240, diffuse large B-Non-Hodgkin Lymphoma, consolidation (PID971 V1.1)
